Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-22T13:13:38.942Z Has data issue: false hasContentIssue false

Campylobacter is the leading cause of bacterial gastroenteritis and dysentery in hospitalized children in the Western Galilee Region in Israel

Published online by Cambridge University Press:  07 April 2010

N. DAYAN
Affiliation:
Department of Paediatrics, Western Galilee Hospital, Nahariya, Israel
D. REVIVO
Affiliation:
Clinical Microbiology Laboratory, Western Galilee Hospital, Nahariya, Israel
L. EVEN
Affiliation:
Department of Paediatrics, Western Galilee Hospital, Nahariya, Israel The Ruth and Bruce Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel
O. ELKAYAM
Affiliation:
Department of Paediatrics, Western Galilee Hospital, Nahariya, Israel
D. GLIKMAN*
Affiliation:
Infectious Diseases Unit, Western Galilee Hospital, Nahariya, Israel The Ruth and Bruce Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel
*
Author for correspondence: D. Glikman, Infectious Diseases Unit, Western Galilee Hospital, PO Box 21, Nahariya, 22100, Israel. (Email: [email protected])
Rights & Permissions [Opens in a new window]

Abstract

Type
Correspondence
Copyright
Copyright © Cambridge University Press 2010

To The Editor:

In their paper, Stein-Zamir et al. describe population-based, age-specific epidemiological trends of enteric bacterial infections in children in the Jerusalem district in Israel during 1990–2008 [Reference Stein-Zamir1]. Overall, during the study period Shigella was the leading bacterial pathogen, especially in children aged <5 years. Shigella infections were characterized by an endemic-epidemic pattern. The incidence of Salmonella infection increased in the early 1990s and then declined after 2000. Campylobacter gastroenteritis rates increased steadily and by 2008 it became the leading cause of diagnosed bacterial enteric infection being particularly predominant in infants aged <6 months.

Previous studies from Israel conducted in the 1990s demonstrated the infrequency of Campylobacter infections in children with gastroenteritis: Finkelstein et al. found Campylobacter in only 2% of hospitalized dysenteric children in one hospital in central Israel [Reference Finkelstein2] and Lerman et al. found that only 1% of children with acute diarrhoea living in a kibbutz in central Israel had Campylobacter infection [Reference Lerman, Slepon and Cohen3].

We recently conducted a retrospective study of all hospitalized children with gastroenteritis in the Western Galilee Hospital in Nahariya, Israel during 24 months in 2007–2009. The hospital serves a population of 500 000 people in the Western Galilee area in northern Israel. In the study, charts of hospitalized children with gastroenteritis of bacterial aetiology were identified and reviewed. We found 99 children admitted with bacterial gastroenteritis; Campylobacter was identified in 61%, Shigella in 24%, and Salmonella in 16%. Of children with dysentery (n=63), Campylobacter was isolated in 72% whereas Shigella was isolated only in 19%. Campylobacter was the infecting cause in 94% of dysenteric children aged <1 year. We also identified nine young, afebrile infants aged <3 months with blood-streaked stools; eight had stool cultures positive for Campylobacter [Reference Dayan4].

Interestingly, in contrast to our findings, the recent European guidelines for the management of acute gastroenteritis in children state that Campylobacter is the most common bacterial pathogen beyond the age of 5 years, implicating different epidemiology of enteropathogens in children in Europe [Reference Guarino5].

Our study supports the new trends among bacterial gastroenteritis pathogens in Israel, and especially for Campylobacter, demonstrated by Stein-Zamir et al. and does so in a different region of Israel, and in hospitalized children. This emphasizes the importance of Campylobacter in Israel as the main pathogen of bacterial gastroenteritis and dysentery, especially in young infants and calls for studies focusing on interventions to decrease the transmission of the pathogen to humans.

Declaration of Interest

None.

The authors reply:

The growing burden of campylobacteriosis in infancy and early childhood is indeed worrying. The predominance of Campylobacter in hospitalized children with gastroenteritis of bacterial aetiology (61%), and specifically in infants aged <1 year (94%), as reported in the above letter by Dayan et al. in Northern Israel during 2007–2009, is noteworthy. Their findings concur with ours on epidemiological trends of enteric bacterial infections in Jerusalem in indicating a consistent rise in the incidence of Campylobacter infections, especially in infants aged <1 year [Reference Stein-Zamir1].

For some years Campylobacter infection notifications have consistently been on the rise in Israel. According to Ministry of Health reports, the number of reported cases increased by 22%, from 4444 in 2008 to 5684 in 2009. Between 2007 and 2009 there was a 38% increase, and from 2005 a 48% increase [2]. The national incidence rate per 100 000 population increased from 40·03 in 2005 to 75·8 in 2009 (RR 1·89, 95% CI 1·81–1·98, P=0·0001). In the Jerusalem district Campylobacter was the predominant bacterial pathogen in infants, accounting for 49·5% and 57% of cases in 2008 and 2009, respectively.

While Shigella infections are traditionally considered to be transmitted from person to person (especially in childcare facilities), Salmonella and Campylobacter are considered to be foodborne and environmental infections.

Campylobacter infections topped the list of zoonotic diseases in the European Union, according to the Community Zoonoses Report for 2007 published by the European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC). According to that report, there were 200 507 cases of Campylobacter in 2007 in the EU compared to 175 561 in 2006, a 14·2% increase [3]. In 2008, Campylobacter continued to be the most commonly reported gastrointestinal bacterial pathogen in humans in the EU, as in the previous 4 years. The number of reported confirmed human campylobacteriosis cases in the EU decreased by 5·0% in 2008 compared to 2007. The reduction in confirmed reported cases was accompanied by a decrease in the overall EU notification rate from 45·2/100 000 population in 2007 to 40·7/100 000 population in 2008 [4].

Considerable veterinary efforts aimed at controlling Salmonella in poultry were fruitful. Similar efforts should be aimed at Campylobacter now. It is well known that Israelis consume plenty of chicken (and chicken soup), so we really need to take care!

References

Stein-Zamir, C, et al. The changing panorama of bacterial enteric infections. Epidemiology and Infection 2009; 137: 15311537.CrossRefGoogle ScholarPubMed
Finkelstein, Y, et al. Clinical dysentery in hospitalized children. Infection 2002; 30: 132135.CrossRefGoogle ScholarPubMed
Lerman, Y, Slepon, R, Cohen, D. Epidemiology of acute diarrheal diseases in children in a high standard of living rural settlement in Israel. Pediatric Infectious Disease Journal 1994; 13: 116122.Google Scholar
Dayan, N, et al. Campylobacter is the leading cause of bacterial gastroenteritis and dysentery among hospitalized children in the Western Galilee area. In: 2010 Israeli Clinical Pediatrics Society Conference, Tel Aviv, 3 February 2010. Abstract 6-04.Google Scholar
Guarino, A, et al. European Society for Paediatric Gastroenterology, Hepatology and Nutrition/European Society for Paediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe. Journal of Pediatric Gastroenterology and Nutrition 2008; 46 (Suppl. 2): S81S122.Google Scholar